Billionaire Hedge Fund Trader Paul Tudor Jones on the Most Important Stock Metric. It’s No Longer Profits (CNBC)
Paul Tudor Jones, the billionaire hedge fund trader who co-founded ESG investing research firm Just Capital, said companies that are motivated solely by profits can create the ability to be amoral in their decision marking. Instead, the companies that are doing the best are focusing on the “most important metrics, which are generally pocketbook issues and work-related,” Jones said.
Brevan Howard Partners Share GBP120m Pandemic Payout (Hedge Week)
Seventeen partners at hedge fund Brevan Howard have shared a bumper GBP120 million payout after profits surged following a series of successful bets during the first year of the coronavirus pandemic, according to reports in The Times and The Daily Telegraph. Founder Alan Howard took the lion’s share earning over GBP55 million in the year to end March 2021, up from GBP29.9 million in the previous twelve months.
Analysis: Elliott, Ancora Lead Hedge Funds in Pushing for More Women on Boards (Reuters)
Jan 12 (Reuters) – Elliott Management Corp and Ancora Advisors LLC led activist hedge funds in pushing for women to join corporate boards last year, as a Wall Street old boys’ network makes strides toward diversity.
Hedge Funds Rocked by Recent IPOs (Institutional Investor)
Once a source of the biggest gains for hedge funds, previously private investments that have recently gone public have plummeted below their IPO prices. More trouble in private investments… or post-private investments. A major source of gains for many hedge funds for most of 2021 has suddenly become a major source of losses. And this recent trend has accelerated amid the recent stock market selloff and increased volatility.
Insider Buying: Radiopharm Theranostics Ltd (ASX:RAD) Insider Buys 100,000 Shares of Stock (ETF Daily News)
Radiopharm Theranostics Ltd (ASX:RAD) insider Riccardo Canevari purchased 100,000 shares of Radiopharm Theranostics stock in a transaction on Friday, January 7th. The shares were acquired at an average price of A$0.37 ($0.27) per share, with a total value of A$37,000.00 ($26,618.71).
Wednesday 1/12 Insider Buying Report: SMAR, VIGL (Nasdaq.com)
At SmartSheet, a filing with the SEC revealed that on Friday, Director James N. White bought 150,000 shares of SMAR, at a cost of $63.07 each, for a total investment of $9.46M. White was up about 9.0% on the buy at the high point of today’s trading session, with SMAR trading as high as $68.76 at last check today. SmartSheet is trading up about 3.7% on the day Wednesday. And at Vigil Neuroscience, there was insider buying on Tuesday, by Director Bruce Booth who purchased 535,000 shares at a cost of $14.00 each, for a trade totaling $7.49M. This purchase marks the first one filed by Booth in the past twelve months. Vigil Neuroscience is trading up about 4.4% on the day Wednesday. Bargain hunters can buy VIGL even cheaper than Booth did, with the stock changing hands as low as $12.01 in trading on Wednesday which is 14.2% below Booth’s purchase price.
